The history of Sildenafil presents a interesting case for stakeholders in the pharmaceutical sector. While initially a blockbuster success, producing vast sums, the exclusivity end and the subsequent entry of generic https://pharma301206.myparisblog.com/42319491/the-little-copyright-and-the-pharmaceutical-industry-a-speculative-play